Bench to Boardroom Technology Showcases 2012

 

 

Home   Agenda   Delegates     Speakers   Technology Showcases   Exhibitors    Workshops     Sponsorship      Venue

 

For the first time, Bench-to-Boardroom will feature great Technology Showcases profiling the very best technologies from world-class companies.

Programme:

Domainex and Cresset BioMolecular Discovery’s Joint Technology Showcase

This Technology Showcase will see Domainex and Cresset BioMolecular Discovery discuss the product development time for new medicines and the significant challenge posed when balancing the up-front investment required with the potential return on that investment given the constraints of patent length and generic competition.

10.45 - Drug Discovery in the Year of the Olympics: Smarter, Faster, Cheaper

Trevor Perrior, Research Director, Domainex

11.10 - Computational Chemistry On-demand

Martin Slater, Director of Consulting, Cresset BioMolecular Discovery

11.35 - Facilitated Q & A

11.45 - Close

 

Kymab, Bicycle Therapeutics and Lonza’s Joint Technology Showcase
This Technology Showcase will see Kymab, Bicycle Therapeutics and Lonza present their leading edge approaches to next generation antibody selection, manufacture and clinical development towards therapeutic and commercial success.

14.15 - Introduction & Welcome

14.20 - Next Generation Human Monoclonal Antibodies

Tom Shepherd, Chief Business Officer, Kymab

14.35 - Combining Advantages of Biologics and NCEs

John Tite, Chief Executive Officer, Bicycle Therapeutics

14.50 - De-risking Protein Therapeutics

Noel Smith, Scientific Leader, Lonza

15.05 - Facilitated Q & A

 

To view information on any of the presenting companies please click here.